Argus is most often covered alongside MarketBeat.com, which appears in 2 of these 3 stories. The clearest coverage concentration is markets: 2 of 3 stories, with the rest divided among 1 other category. That works out to roughly 0.4 stories per week across a 54-day span.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Argus
Argus is most often covered alongside MarketBeat.com, which appears in 2 of these 3 stories. The clearest coverage concentration is markets: 2 of 3 stories, with the rest divided among 1 other category. That works out to roughly 0.4 stories per week across a 54-day span. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window. Their average consequence score of 5.3 runs below the beat's 5.7 for that window. We currently track 3 Finance stories that mention Argus, published between August 3, 2026 and September 25, 2026.
Stories tracked
3
Per week
0.4
Sources per story
2
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 1034 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Argus. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen upgraded CVS Health to strong-buy, adding to 22 buy ratings and a $107.24 consensus target that implies 23% upside from Friday's $87.02 open. Macy's and NewJersey Resources were also upgraded, signaling broad analyst optimism.
Analysts remain mostly bullish on RTX and GE Vernova after July earnings, lifting price targets to as high as $250 and $1,338 respectively. Friday's gains came on unusually light volume, raising questions about conviction. Finance readers get a breakdown of target upside, valuation, and risk metrics.
Canadian Pacific Kansas City posted a $0.03 EPS beat and 12.6% revenue growth, maintaining strong margins. With a consensus Buy rating and price targets as high as $105, the stock offers a defensive growth story for investors.